IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients;Polymorphismes des gènes de l'IL1/IL1 Ra, CTLA-4 et Apo1/Fas et susceptibilité à la néphropathie à IgA chez des patients Tunisiens

Tunisie Medicale

Volumn 88, Issue 11, 2010, Pages 789-793

  Gorgi, Yousr ^a   Sfar, Imen ^a   Goucha, Rym ^a   Aouadi, Houda ^a   Amri, Mohamed ^a   Makhlouf, Mouna ^a   Ben Romdhane, Thouraya ^a   Cherif, Mejda ^a   Jendoubi Ayed, Salwa ^a   Ben Abdallah, Taïeb ^a   Ayed, Khaled ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Apo Fas; CTLA 4; Gene; IgA nephropathy; IL1; Polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD95; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNISIA;

EID: 78149311865     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Monteiro RC, Leroy V, Launay P, Moura IC. Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors. Med Sci 2003; 19: 1233-41.
2. Chen A, Chen WP, Sheu LF, Lin CY. Patogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 1994; 173: 119-26.
3. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H, Kurokawa K. Glomerular Fc alphaR expression and disease activity in IgA nephropathy. Am J Kidney Dis 1997; 30: 389-96.
4. Lim CS, Yoon HJ, Kim YS, Ahn C, Han JS. Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy. Nephrology (Carlton) 2003; 8: 21-7.
5. Haas M. Histology and immunohistology of IgA nephropathy. J Nephrol 2005; 18: 676-80.
6. Zwirner J, Burg M, Schulze M, et al. Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney Int 1997; 51: 1257-64.
7. Chun Soo Lim, Shouhuan Zheng, Yon Su Kim, et al. Thi/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrology Dialysis Transplantation 2001; 16: 269-75.
8. Chin HJ, Na KY, Kim SJ, et al.. Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea. J Korean Med Sci 2005; 20: 989-93.
9. Schena FP, Cerullo G, Torres DD, et al. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet 2006; 14: 488-96.
10. Taniguchi Y, Yorioka N, Oda H, Yamakido M. Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study. Nephron 1996; 74: 652-60.
11. Liu ZH, Cheng ZH, Yu YS, Tang Z, Li LS. Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schonlein nephritis and IgA nephropathy? Kidney Int 1997; 51: 1938-42.
12. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-9.
13. Watanabe M, Iwano M, Akai Y, et al. Association of interleukin- 1 receptor antagonist gene polymorphism with IgA nephropathy. Nephron 2002; 91: 744-6.
14. Kodama S, Suzuki M, Arita M, Mogi G. Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis. Clin Exp Immunol 2001; 123: 301-8.